Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion type Assertion NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_head.
- NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion description "[To clarify the molecular mechanisms through which malignant changes are activated in endometrium, this study aims to examine the expression profiles of wild-type ER-alpha and their splice variants and to assess the number of coexisting mRNA isoforms of ER-alpha in normal endometrium as well as in endometrial hyperplasia and endometrial endometrioid adenocarcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_provenance.
- NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion evidence source_evidence_literature NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_provenance.
- NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion SIO_000772 17561234 NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_provenance.
- NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion wasDerivedFrom befree-20140225 NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_provenance.
- NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_assertion wasGeneratedBy ECO_0000203 NP478902.RAKG8mlS7wXKeUvn2LrrjKMDnk-Nk619atlYN9sVgrYB8130_provenance.